Chengdu Kanghua Biological Products (300841) - Total Liabilities

Latest as of September 2025: CN¥430.82 Million CNY ≈ $63.04 Million USD

Based on the latest financial reports, Chengdu Kanghua Biological Products (300841) has total liabilities worth CN¥430.82 Million CNY (≈ $63.04 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Chengdu Kanghua Biological Products (300841) cash flow conversion to assess how effectively this company generates cash.

Chengdu Kanghua Biological Products - Total Liabilities Trend (2015–2024)

This chart illustrates how Chengdu Kanghua Biological Products's total liabilities have evolved over time, based on quarterly financial data. Check how resilient are Chengdu Kanghua Biological Products's assets to evaluate the company's liquid asset resilience ratio.

Chengdu Kanghua Biological Products Competitors by Total Liabilities

The table below lists competitors of Chengdu Kanghua Biological Products ranked by their total liabilities.

Company	Country	Total Liabilities
Primax Electronics Ltd TW:4915	Taiwan	NT$30.09 Billion
Hengerda New Materials (Fujian) Co. Ltd. SHE:300946	China	CN¥436.68 Million
Meitav Dash Investments Ltd TA:MTDS	Israel	ILA3.61 Billion
Yunnan Hongxiang Yixintang SHE:002727	China	CN¥8.37 Billion
Collegium Pharmaceutical Inc NASDAQ:COLL	USA	$1.33 Billion
TRANSFORMERS AND RECTIFIERS INDIA NSE:TARIL	India	Rs10.21 Billion
International General Insurance Holdings Ltd NASDAQ:IGIC	USA	$1.44 Billion

Liability Composition Analysis (2015–2024)

This chart breaks down Chengdu Kanghua Biological Products's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market cap of Chengdu Kanghua Biological Products.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	5.85	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.12	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.11	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Chengdu Kanghua Biological Products's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Chengdu Kanghua Biological Products (2015–2024)

The table below shows the annual total liabilities of Chengdu Kanghua Biological Products from 2015 to 2024.

Year	Total Liabilities	Change
2024-12-31	CN¥580.07 Million ≈ $84.88 Million	-16.56%
2023-12-31	CN¥695.22 Million ≈ $101.73 Million	+9.41%
2022-12-31	CN¥635.40 Million ≈ $92.98 Million	+82.72%
2021-12-31	CN¥347.74 Million ≈ $50.89 Million	+100.72%
2020-12-31	CN¥173.24 Million ≈ $25.35 Million	+51.32%
2019-12-31	CN¥114.49 Million ≈ $16.75 Million	-3.29%
2018-12-31	CN¥118.37 Million ≈ $17.32 Million	+37.05%
2017-12-31	CN¥86.38 Million ≈ $12.64 Million	-70.94%
2016-12-31	CN¥297.23 Million ≈ $43.49 Million	+9.03%
2015-12-31	CN¥272.61 Million ≈ $39.89 Million	--

About Chengdu Kanghua Biological Products

SHE:300841 China Biotechnology

Market Cap

$1.09 Billion

CN¥7.42 Billion CNY

Market Cap Rank

#8756 Global

#2306 in China

Share Price

CN¥57.08

Change (1 day)

-0.90%

52-Week Range

CN¥52.31 - CN¥92.06

All Time High

CN¥399.08